Advertisement

Lessons Learned in Value-Based Contracts

Interest in value-based contracts continues to grow, but the most of these arrangements are not publicly known. A survey of 11 pharmaceutical manufacturers and...

Gene Therapy Management in Europe Versus the United States

The United States and Europe face many similar challenges in the management of gene therapies, including high upfront costs and the logistics of getting...

Optimizing Payer and Manufacturer Communication

The legislative and regulatory environment governing proactive communication between manufacturers and payers continues to evolve, according to experts at the AMCP Annual Meeting. Insights and...

Marketplace Trends: Specialty Spending, Generics and Biosimilars, Medication Adherence, and More

Total spending on medicine in the United States was $435 billion in 2017, with a growth of only 1.4%. Specialty growth is outpacing traditional...

General Session: Innovation and Change in the Healthcare System

AMCP CEO Susan Cantrell, RPh, CAE, began the General Session by discussing the trends in healthcare: “We need to free up space in the...

A Look at the Specialty Pharmacy Pipeline

Specialty drugs are those that involve frequent dosing adjustments and intensive clinical monitoring, as well as intensive patient training and compliance assistance, limited distribution,...

Change on the Horizon for the Management of Oncology

Oncology care is undergoing seismic change, driven largely by three factors: value-based care, precision medicine, and digital health. “The ground is shifting right under...

A Program Example to Combat Opioid Misuse and Abuse

The United States comprises approximately 4.4% of the global population but consumes 80% of opioids worldwide, and the majority of misuse comes from legally...

A Look at Gene Therapies in Development

Gene therapy involves the administration of genetic material to modify or manipulate the expression of genes or alter the biological properties of living cells....

CAR-T, CRISPR, and More Updates in Cancer Care and How to Pay for Them

Cancer remains a leading cause of morbidity and mortality in the United States, and the cost of cancer care is projected to reach $156...
Advertisement